# Paul Sorajja, M.D., Clinical Investigator, Minneapolis, MN – FDA Inspections

Source: https://www.keypedia.com/companies/paul-sorajja-md-clinical-investigator/3122779d-6e12-46e7-a5b3-609479cb3205

> Inspection records and compliance data for Paul Sorajja, M.D., Clinical Investigator in Minneapolis, Minnesota. 3 FDA inspections on record, 2 Form 483s, last inspected May 02, 2025.

---

## Details

- Name: Paul Sorajja, M.D., Clinical Investigator
- FEI Number: 3015054234
- Address Line 1: Minneapolis Heart Institute, 920 E 28th St Ste 300
- City: Minneapolis
- State: Minnesota
- Zip Code: 55407
- Country Name: United States
- Address: Minneapolis Heart Institute, 920 E 28th St Ste 300, Minneapolis, Minnesota 55407, United States
- Country: United States

## Related Documents

- FDA Inspection 1269127 - Paul Sorajja, M.D., Clinical Investigator - 2025-05-02 — source: FDA, date: May 2, 2025
- FDA Inspection 1269127 - Paul Sorajja, M.D., Clinical Investigator - 2025-05-02 — classification: No Action Indicated (NAI), source: FDA, date: May 2, 2025
- [483 - Paul Sorajja, M.D., Clinical Investigator - 2023-08-25](https://www.keypedia.com/records/483/paul-sorajja-md-clinical-investigator/8bbf414b-2fb0-4d81-a56a-aa72dfcfe6bf) — source: FDA, date: August 25, 2023
- [FDA Inspection 1215907 - Paul Sorajja, M.D., Clinical Investigator - 2023-08-25](https://www.keypedia.com/records/fda_inspections/paul-sorajja-md-clinical-investigator/5eca3c30-5a14-41a0-81d4-3ab51afd79df) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 25, 2023
- [483 - Paul Sorajja, M.D., Clinical Investigator - 2019-03-22](https://www.keypedia.com/records/483/paul-sorajja-md-clinical-investigator/2e0a3a03-63fd-4396-b833-b33156fa67e1) — source: FDA, date: March 22, 2019
- [FDA Inspection 1083532 - Paul Sorajja, M.D., Clinical Investigator - 2019-03-22](https://www.keypedia.com/records/fda_inspections/paul-sorajja-md-clinical-investigator/4889b481-2be8-47f4-a99b-c4590cffcadc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2019
- FDA Inspection 1083532 - Paul Sorajja, M.D., Clinical Investigator - 2019-03-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2019

## Related Companies

- [Microbiologics Inc](https://www.keypedia.com/companies/microbiologics-inc/468a8404-40bd-4e42-bbee-edaa7ffece55)
- [Anesthesia Associates Inc](https://www.keypedia.com/companies/anesthesia-associates-inc/e8001b50-693e-452c-b95a-ba4d56d5d3aa)
- [Alpha ProTech Inc.](https://www.keypedia.com/companies/alpha-protech-inc/afa89840-6bdc-4b2e-80d1-e80f7fb8dc74)
- [Neurodynamics, Inc.](https://www.keypedia.com/companies/neurodynamics-inc/d6d11616-e9b8-47b1-aaca-e2558babb104)
- [Tecomet, Inc.](https://www.keypedia.com/companies/tecomet-inc/3edd907b-3baf-4433-bdbe-af417a02a831)
- [Full Range Rehab LLC](https://www.keypedia.com/companies/full-range-rehab-llc/80c9d80e-b15f-4db1-97ed-25f0a986395e)
- [Exact Medical Manufacturing, Inc.](https://www.keypedia.com/companies/exact-medical-manufacturing-inc/3c92bb56-3cab-4bd5-bf14-c3d5bb0df04e)
- [Isomedix Operations Inc.](https://www.keypedia.com/companies/isomedix-operations-inc/0c78fec2-88ae-46ae-b5c4-cecffb9fdc50)
- [Kimberly-Clark Corporation](https://www.keypedia.com/companies/kimberly-clark-corporation/d1047438-8f53-4a80-b170-74c8e34d2c0c)
- [Terumo Cardiovascular Systems Corp](https://www.keypedia.com/companies/terumo-cardiovascular-systems-corp/7141c116-e93e-4ebf-bb9e-a06e03d3bc48)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/kellie-l-thommes/255a1b92-cd56-41f5-9622-82e8a629e153)
- [Investigator](https://www.keypedia.com/people/sharon-l-matson/1d2e6d91-1d00-455d-a2e6-a73b1c6b82cc)